Home › Stomach Cancer › Alaska › Anchorage
Stomach Cancer clinical trials in Anchorage, AK
3 studies for Stomach Cancer are looking for participants at sites in and around Anchorage (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- and 3 more
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Anchorage
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Alaska Oncology and Hematology, Anchorage
About Stomach Cancer
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
More about Stomach Cancer on MedlinePlus
Stomach Cancer trials in other cities
- Houston, TX42 studies
- Boston, MA32 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA22 studies
- Baldwin Park, CA22 studies
- Arlington, VA20 studies
- Dallas, TX19 studies
- San Antonio, TX19 studies
- Grand Rapids, MI18 studies
- St. Louis, MO18 studies
- Washington, DC16 studies
Other studies in Anchorage
- Non-Small Cell Lung Cancer8 studies
- Ovarian Cancer7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Endometrial Cancer4 studies
- Prostate Cancer4 studies
- Pancreatic Cancer4 studies
- Cancer (all types)3 studies
- Melanoma3 studies
- Acute Biphenotypic Leukemia3 studies
- Esophageal Cancer3 studies
- Colorectal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.